CervoMed Announces Completion of Enrollment in Phase 2 Study of Neflamapimod for Nonfluent Variant Primary Progressive Aphasia, a Type of Frontotemporal Dementia
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as climbing oil, yields amplify inflation fears
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
| (NASDAQ: CRVO) | Delayed: 3.25 +0.07 (2.20%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.18 | 52 Week High | $ | |||
| Open | $3.15 | 52 Week Low | $ | |||
| Day High | $3.29 | P/E | N/A | |||
| Day Low | $3.13 | EPS | $ | |||
| Volume | 199,574 | |||||
